INDV vs LQDA: stock comparison and AI forecast
Indivior Pharmaceuticals, Inc. (INDV) and Liquidia Corp (LQDA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
INDV Indivior Pharmaceuticals, Inc.
- Market Cap
- $4.17B
- P/E Ratio
- 8.6x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
LQDA Liquidia Corp
- Market Cap
- $4.03B
- P/E Ratio
- 104.8x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- INDV and LQDA have similar market capitalizations ($4.17B and $4.03B).
- INDV trades at 8.6 times trailing earnings, LQDA at 104.8 times.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | INDV | LQDA |
|---|---|---|
| Market Cap | $4.17B | $4.03B |
| P/E Ratio | 8.63x | 104.79x |
| P/B Ratio | – | 20.67x |
| EPS | $4.10 | $0.43 |
| Book Value/Share | – | $2.18 |
| Revenue/Share | $11.63 | $5.07 |
| FCF/Share | $0.26 | $1.68 |
Profitability & Margins
| Metric | INDV | LQDA |
|---|---|---|
| ROIC | – | 50.7% |
| Gross Margin | 84.8% | 98.7% |
| Operating Margin | 41.0% | 37.1% |
| Net Margin | 32.1% | – |
| EBT Margin | 39.6% | 35.2% |
| Tax Rate | 16.5% | 6.8% |
Financial Health
| Metric | INDV | LQDA |
|---|---|---|
| Current Ratio | 0.61x | 2.31x |
| Quick Ratio | 0.50x | 2.12x |
| D/E Ratio | – | 1.67x |
| Financial Leverage | – | 2.67x |
| Interest Coverage | 6.8x | – |
| Working Capital | -$501M | $248M |
Cash Flow
| Metric | INDV | LQDA |
|---|---|---|
| Operating Cash Flow | $96M | $168M |
| Free Cash Flow | $31M | $151M |
| Capital Spending | -$65M | -$17M |
| OCF Growth YoY | -52.7% | – |
| FCF Growth YoY | -79.8% | – |
| FCF/Sales | 2.3% | 33.2% |
| CapEx/Sales | 4.7% | 3.8% |
Operational Efficiency
| Metric | INDV | LQDA |
|---|---|---|
| Asset Turnover | – | 0.87x |
| Receivables Turnover | 5.0x | 4.2x |
| Inventory Turnover | 1.4x | 0.2x |
| Fixed Assets Turnover | 7.8x | 13.1x |
| Days Sales Outstanding | 73 days | 87 days |
| Days Inventory | 261 days | 2227 days |
| Payables Period | 49 days | 785 days |
| Cash Conversion Cycle | 285 days | 1530 days |
Income Statement
| Metric | INDV | LQDA |
|---|---|---|
| Total Revenue | $1.37B | $454M |
| Operating Income | $558M | $169M |
| Net Income | $436M | – |
| R&D Expense | $54M | $56M |
| SG&A Expense | $553M | $223M |
| Cost of Goods Sold | $208M | $6M |
Dividend & Shareholder Information
| Metric | INDV | LQDA |
|---|---|---|
| Shares Outstanding | 118M | 90M |
| Net Income Growth | 305.6% | – |
| EPS Growth | 1123.9% | – |
INDV vs LQDA: stock comparison and AI forecast
Which is bigger, INDV or LQDA?
INDV and LQDA have similar market capitalizations ($4.17B and $4.03B).
Which is cheaper on earnings, INDV or LQDA?
INDV trades at 8.6 times trailing earnings, LQDA at 104.8 times.
Which one does Intratio's AI model rank higher, INDV or LQDA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.